Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Features of Cutaneous Paraneoplastic Syndromes in Hodgkin Lymphoma.
McCormick BJ, Zieman D, Sluzevich JC, Alhaj Moustafa M. McCormick BJ, et al. Among authors: alhaj moustafa m. J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241255840. doi: 10.1177/23247096241255840. J Investig Med High Impact Case Rep. 2024. PMID: 38767173 Free PMC article.
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.
Wang TP, Ahn KW, Shadman M, Kaur M, Ahmed N, Bacher U, Cerny J, Chen A, Epperla N, Frigault M, Grover N, Haverkos B, Hill B, Hossain N, Iqbal M, Jain T, Krem MM, Maakaron J, Modi D, Alhaj Moustafa M, Riedell P, Savani B, Sica RA, Sureda A, Wudhikarn K, Herrera AF, Sauter C, Hamadani M, Jimenez Jimenez A. Wang TP, et al. Among authors: alhaj moustafa m. Leukemia. 2024 May 15. doi: 10.1038/s41375-024-02242-6. Online ahead of print. Leukemia. 2024. PMID: 38750138
Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report.
Mosalem O, Pai T, Alqawasma M, Shaikh M, Li KD, Alhaj Moustafa M. Mosalem O, et al. Among authors: alhaj moustafa m. J Blood Med. 2024 Jan 24;15:29-34. doi: 10.2147/JBM.S444004. eCollection 2024. J Blood Med. 2024. PMID: 38283854 Free PMC article.
Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis.
Wolf EB, Li D, Fernandez AJ, Gardner LB, Rivera CE, Wysokinska EM, Shaikh ME, Tun HW, Roy V, Alhaj Moustafa M. Wolf EB, et al. Among authors: alhaj moustafa m. J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231209543. doi: 10.1177/23247096231209543. J Investig Med High Impact Case Rep. 2023. PMID: 37919949 Free PMC article.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Alhaj Moustafa M, Parrondo R, Abdulazeez MF, Roy V, Sher T, Alegria VR, Warsame RM, Fonseca R, Rasheed A, Gonsalves WI, Kourelis T, Kapoor P, Buadi FK, Dingli D, Hayman SR, Reeder CB, Chanan-Khan AA, Ailawadhi S. Alhaj Moustafa M, et al. Anticancer Drugs. 2024 Jan 1;35(1):63-69. doi: 10.1097/CAD.0000000000001520. Epub 2023 Apr 6. Anticancer Drugs. 2024. PMID: 37067996
Timing of CAR-T therapy in follicular lymphoma.
Alhaj Moustafa M. Alhaj Moustafa M. Expert Rev Anticancer Ther. 2023 Apr;23(4):347-349. doi: 10.1080/14737140.2023.2185222. Epub 2023 Mar 1. Expert Rev Anticancer Ther. 2023. PMID: 36825538 No abstract available.
41 results